These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2552794)

  • 1. Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast.
    Bonetti F; Colombari R; Manfrin E; Zamboni G; Martignoni G; Mombello A; Chilosi M
    Am J Clin Pathol; 1989 Oct; 92(4):491-5. PubMed ID: 2552794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
    Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
    Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoperoxidase localization of lactalbumin in malignant breast neoplasms.
    Clayton F; Ordóñez NG; Hanssen GM; Hanssen H
    Arch Pathol Lab Med; 1982 Jun; 106(6):268-70. PubMed ID: 6284085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD24 is a marker for human breast carcinoma.
    Fogel M; Friederichs J; Zeller Y; Husar M; Smirnov A; Roitman L; Altevogt P; Sthoeger ZM
    Cancer Lett; 1999 Aug; 143(1):87-94. PubMed ID: 10465342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a membrane glycoprotein in benign fibrocystic disease and infiltrating duct carcinomas of the human breast with the use of a monoclonal antibody to guinea pig milk fat globule membrane.
    Greenwalt DE; Johnson VG; Kuhajda FP; Eggleston JC; Mather IH
    Am J Pathol; 1985 Mar; 118(3):351-9. PubMed ID: 2579563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
    Sappino AP; Skalli O; Jackson B; Schürch W; Gabbiani G
    Int J Cancer; 1988 May; 41(5):707-12. PubMed ID: 2835323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical evidence of vimentin in fibrocystic breast disease and mammary carcinoma].
    Alexiev B; Valkov I; Popov A
    Zentralbl Pathol; 1992 Sep; 138(4):284-8. PubMed ID: 1329942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.
    Rossiello R; Carriero MV; Giordano GG
    J Clin Pathol; 1984 Jan; 37(1):51-5. PubMed ID: 6323544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue.
    Thompson SJ; Schatteman GC; Gown AM; Bothwell M
    Am J Clin Pathol; 1989 Oct; 92(4):415-23. PubMed ID: 2552791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney.
    Pea M; Bonetti F; Zamboni G; Martignoni G; Riva M; Colombari R; Mombello A; Bonzanini M; Scarpa A; Ghimenton C
    Pathology; 1991 Jul; 23(3):185-8. PubMed ID: 1664078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
    Egan MJ; Newman J; Crocker J; Collard M
    Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry.
    Dwarakanath S; Lee AK; Delellis RA; Silverman ML; Frasca L; Wolfe HJ
    Hum Pathol; 1987 Nov; 18(11):1144-8. PubMed ID: 2824323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of carcinoembryonic antigen (CEA) in breast carcinoma using an immunohistochemical method: morpho-functional evaluations and diagnostic uses].
    Lanzafame S; Puzzo L; Bartoloni G
    Pathologica; 1985; 77(1050):373-84. PubMed ID: 3010221
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
    Dairkee SH; Puett L; Hackett AJ
    J Natl Cancer Inst; 1988 Jul; 80(9):691-5. PubMed ID: 2453676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B; Rutter G; Stegner HE; Böcker W
    Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the microTICAS image analysis system.
    Franklin WA; Bibbo M; Doria MI; Dytch HE; Toth J; DeSombre E; Wied GL
    Anal Quant Cytol Histol; 1987 Aug; 9(4):279-86. PubMed ID: 2822057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.